Stevens Capital Management’s Medifast MED Stock Holding History

Stevens Capital Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-977	Closed	-$216K	–	825
2018 Q3	$216K	Buy	+977	New	+$198K	0.01%	640
2017 Q4	–	Sell	-3,941	Closed	-$234K	–	956
2017 Q3	$234K	Sell	3,941 -3,571	-48%	-$178K	0.01%	722
2017 Q2	$312K	Buy	+7,512	New	+$327K	0.01%	667
2017 Q1	–	Sell	-5,919	Closed	-$246K	–	1006
2016 Q4	$246K	Sell	5,919 -4,303	-42%	-$173K	0.01%	733
2016 Q3	$386K	Buy	+10,222	New	+$366K	0.02%	632
2014 Q2	–	Sell	-10,052	Closed	-$292K	–	1207
2014 Q1	$292K	Buy	+10,052	New	+$269K	0.01%	798
2013 Q4	–	Sell	-10,081	Closed	-$271K	–	1146
2013 Q3	$271K	Sell	10,081 -3,125	-24%	-$83.6K	0.01%	821
2013 Q2	$340K	Buy	+13,206	New	+$347K	0.01%	677

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Stevens Capital Management's MED Position: Q4 2018 in Review

Stevens Capital Management sold out of Medifast (MED) in Q4 2018, closing a stake of 977 shares — an estimated $216K sold.

Stevens Capital Management first reported a position in MED in Q2 2013 and held it in 8 quarters. The position peaked at $386K in Q3 2016. 247 funds tracked by Wall St. Rank hold MED as of Q4 2018.

Stevens Capital Management reported no remaining Medifast position as of Q4 2018 after selling out during the quarter.
Stevens Capital Management sold 977 Medifast shares in Q4 2018, an estimated $216K.
Stevens Capital Management first reported a position in Medifast in Q2 2013 and held it in 8 quarters.
Stevens Capital Management's Medifast position peaked at $386K in Q3 2016.
247 funds tracked by Wall St. Rank held Medifast as of Q4 2018.

Based on Stevens Capital Management's 13F filing for Q4 2018, filed 6 Feb 2019.